Results 281 to 290 of about 2,391,716 (307)
Some of the next articles are maybe not open access.

Assessing Early Postoperative Benefits of a Nerve Block: Methodology Is Important

The Annals of Thoracic Surgery, 2022
Xin Luo, Fu-Shan Xue, Cheng-Wen Li
openaire   +2 more sources

[Assessing the added benefit of new ophthalmic drugs : Which additional insights can be extracted from the early benefit assessment?]

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 2019
Until now six ophthalmic agents have undergone the German early benefit assessment according to § 35a Social Security Code (SGB) V in a total of eleven indications. Only one agent (ocriplasmin) was recognized by the Federal Joint Committee as having an added benefit based on submitted study data for a subpopulation (indication of a considerable added ...
M, Appelrath, G, Glaeske
openaire   +1 more source

[Subgroups in the early benefit assessment of pharmaceuticals: a methodical review].

Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen, 2016
Benefit assessments according to Sect. 35a of the Social Code Book V are frequently divided into subsets of populations. This division of therapeutic indications is evident in almost every other of the completed appraisals by the Federal Joint Committee (G-BA).
Andrej, Rasch   +1 more
openaire   +1 more source

Cancer Statistics, 2021

Ca-A Cancer Journal for Clinicians, 2021
Rebecca L Siegel, Kimberly D Miller
exaly  

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

Ca-A Cancer Journal for Clinicians, 2021
Hyuna Sung   +2 more
exaly  

Cancer statistics, 2022

Ca-A Cancer Journal for Clinicians, 2022
Rebecca L Siegel   +2 more
exaly  

HTA122 Health-Related Quality of Life in the German Early Benefit Assessment

Value in Health, 2022
M Barth   +4 more
openaire   +1 more source

Cancer statistics, 2023

Ca-A Cancer Journal for Clinicians, 2023
Rebecca L Siegel   +2 more
exaly  

Cancer statistics, 2020

Ca-A Cancer Journal for Clinicians, 2020
Rebecca L Siegel, Kimberly D Miller
exaly  

Home - About - Disclaimer - Privacy